Even in patients of both sexes selected for high PD-1 expression on their NSCLC cells, the effect of anti-PD-1/anti-PD-L1 monotherapy was much stronger in men than in women who required chemotherapy additionally to achieve similar benefit (112). Here, CD274 is linked to non-small cell lung carcinoma.